A study by Marian Walhout, PhD, and colleagues, shows that C. elegans, fed a diet of E.coli bacteria, are 100 times more sensitive to the chemotherapy drug floxuridine, commonly used to treat colon cancer, than worms fed different bacteria. These findings suggest that the bacteria residing in your digestive tract may play an important role in your ability to respond to chemotherapy. Results of the study were published in Cell.
The 44th annual Commencement Exercises on Sunday, June 4, UMass Medical School will award honorary degrees to ground-breaking physician, scientist and academic health leader Valerie Montgomery Rice, MD; humanitarian and businessman Víctor Grífols, president of Grifols; and Patricia Donahoe, MD, a renowned pediatric surgeon and cancer researcher.
The use of antipsychotic medication in nearly 100 Massachusetts nursing homes was significantly reduced when staff members were trained to recognize challenging behaviors of cognitively impaired residents as communication of their unmet needs, according to a new study led by Jennifer Tjia, MD, MSCE.
UMass Medical School will invest three faculty members into newly endowed chairs and three more to existing endowed chairs, as approved by a vote of the UMass Board of Trustees at its April 12 meeting. Two of the newly funded chairs, to be held by Mark Johnson, MD, and Marian Walhout, PhD, were made possible through the generosity of Maroun Semaan, co-founder, director and president of Petrofac Group.
Job Dekker, PhD, has been recognized by the Biochemical Society, based in London, as the inaugural recipient of the International Award.
Michele P. Pugnaire, MD, will step down from the role of senior associate dean for educational affairs in July, according to an announcement by Dean Terence R. Flotte.
UMass Medical School depression expert Anthony Rothschild, MD, is conducting a clinical trial of ketamine for patients with treatment-resistant depression.
Javier Elbio Irazoqui, PhD, associate professor of microbiology & physiological systems, is interested in fundamental mechanisms of innate immunity and inflammation.
Sherry Pagoto, PhD, professor of medicine, was inducted as the Society of Behavioral Medicine president-elect at the society’s annual meeting on April 1.
Jeanne Lawrence, PhD, and Lisa Hall-Anderson, PhD, show that “human satellite II,” an exceptionally high-copy but unexplored sequence of the human genome thought of as “junk DNA,” has a surprising ability to impact master regulators of our genome, and it goes awry in 50 percent of tumors.